4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-032897
SVP,Clinical & Medical Affairs sold 539,283 shares at an average $2.45 ($1,321,329)
- SVP,Clinical & Medical Affairs acquired 510,838 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hogge Gary S. · SVP,Clinical & Medical Affairs
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-28 | Exercise or conversion : show line 1 in the form | +185,000 | $0.69 | $128,002 | 213,445 | D |
| 2021-12-28 | Exercise or conversion : show line 2 in the form | +236,899 | $2.11 | $499,857 | 450,344 | D |
| 2021-12-28 | Exercise or conversion : show line 3 in the form | +79,689 | $1.14 | $90,845 | 530,033 | D |
| 2021-12-28 | Sale : show line 4 in the form | −501,588 | $2.45 | $1,228,891 | 28,445 | D |
| 2021-12-29 | Exercise or conversion : show line 5 in the form | +9,250 | $0.69 | $6,400 | 37,695 | D |
| 2021-12-29 | Sale : show line 6 in the form | −9,250 | $2.49 | $23,033 | 28,445 | D |
| 2021-12-29 | Sale : show line 7 in the form | −28,445 | $2.44 | $69,406 | 0 | D |
| Open-market sales · 539,283 sh · avg $2.45 · $1,321,329 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-28 | Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) | −185,000 | 259,000 | D |
| 2021-12-28 | Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) | −236,899 | 10,301 | D |
| 2021-12-28 | Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) | −79,689 | 32,811 | D |
| 2021-12-29 | Exercise or conversion : show line 11 in the form Employee Stock Option (right to buy) | −9,250 | 249,750 | D |
Loading xslF345X03/ownership.xml…